Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Portage Biotech Inc Ord (NQ: PRTG )

4.400 -0.220 (-4.76%)
Streaming Delayed Price Updated: 1:57 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Portage Biotech Inc Ord

< Previous 1 2 3 4 Next >
Mid-Afternoon Market Update: Dow Jumps Over 300 Points; Portage Biotech Shares Slide
Toward the end of trading Thursday, the Dow traded up 1.03% to 34,222.59 while the NASDAQ rose 0.74% to 14,377.16. The S&P also rose, gaining 0.67% to 4,270.15. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq, S&P 500 Nab More Fresh Records, Dow Up Triple Digits
It's another sunny day on Wall Street, as investors brush off inflation fears and lackluster jobless data. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Mid-Day Market Update: Rite Aid Falls On Downbeat Sales; Marin Software Shares Gain
Midway through trading Thursday, the Dow traded up 0.85% to 34,161.06 while the NASDAQ rose 0.80% to 14,386.13. The S&P also rose, gaining 0.61% to 4,267.52. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 27.11% to $4.5 during Thursday's regular session. As of 12:30 EST, this security is trading at a... 
Via Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
Gainers Marin Software Incorporated (NASDAQ: MRIN) jumped 58% to $2.70 after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne... 
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; Accenture Reports Upbeat Q3 Results
Following the market opening Thursday, the Dow traded up 0.76% to 34,130.38 while the NASDAQ rose 0.75% to 14,379.10. The S&P also rose, gaining 0.54% to 4,264.62. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Portage Biotech Inc. Announces Pricing of Public Offering of 1,000,000 Ordinary Shares
Westport, Connecticut--(Newsfile Corp. - June 24, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) ("Portage" or the "Company") a clinical-stage immuno-oncology... 
Via Newsfile
Topics Regulatory Compliance
Exposures Legal Regulatory
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Aravive (NASDAQ:ARAV) stock moved upwards by 21.61% to $6.47 during Thursday's pre-market session. The company's market cap stands at $131.9 million. Arcus... 
Via Benzinga
25 Stocks Moving in Thursday's Pre-Market Session
Gainers Marin Software Incorporated (NASDAQ: MRIN) rose 43.3% to $2.45 in pre-market trading after the company announced it has added the ability to manage Instacart Ads to its... 
Via Benzinga
Portage Biotech Inc. Announces Proposed Offering of Ordinary Shares
Westport, Connecticut--(Newsfile Corp. - June 23, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) ("Portage" or the "Company") a clinical-stage immuno-oncology... 
Via Newsfile
Topics Regulatory Compliance
Exposures Legal Regulatory
44 Biggest Movers From Yesterday
Gainers Alfi, Inc. (NASDAQ: ALF) shares jumped 108.9% to settle at $16.29 on Tuesday following exclusive Benzinga reporting the company will buyback up to $2 million of its... 
Via Benzinga
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Exposures Product Safety
Portage Biotech Highlights Safety and Survival Data from Intensity Therapeutics' IT-01 Study of INT230-6 (PORT-1) at ASCO 2021 Annual Meeting
- Data from the IT-01 trial demonstrate the safety of INT230-6... 
Via Newsfile
Portage Biotech Announces Voluntary Delisting from the Canadian Securities Exchange
Westport, Connecticut--(Newsfile Corp. - April 16, 2021) - Portage Biotech Inc., (NASDAQ: PRTG) (CSE: PBT.U) ("Portage" or the "Company") a... 
Via Newsfile
Portage Biotech Highlights First Patient Dosed in PRECIOUS-01 Study of PORT-3 for the Treatment of NY-ESO-1 Positive Solid Tumors
- Novel platform allows co-targeting of iNKT cells and tumor antigens... 
Via Newsfile
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.